John Hunter
Chief Tech/Sci/R&D Officer bei FIBROGEN, INC.
Profil
John Hunter is currently the Chief Scientific Officer at FibroGen, Inc. He previously worked as a Senior Director at XOMA Corp., Chief Scientific Officer at Compugen Ltd., Vice President-Antibody R&D at Compugen, Inc. (United States), and Chief Executive & Scientific Officer at Keyhole Therapeutics, Inc. Dr. Hunter received his undergraduate degree from Hartwick College and his doctorate from The University of California, San Francisco.
Aktive Positionen von John Hunter
Unternehmen | Position | Beginn |
---|---|---|
FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 12.07.2021 |
Ehemalige bekannte Positionen von John Hunter
Unternehmen | Position | Ende |
---|---|---|
XOMA CORPORATION | Director/Board Member | - |
COMPUGEN LTD. | Chief Tech/Sci/R&D Officer | - |
Keyhole Therapeutics, Inc. | Chief Executive Officer | - |
Compugen, Inc. (United States) | Corporate Officer/Principal | - |
Ausbildung von John Hunter
Hartwick College | Undergraduate Degree |
The University of California, San Francisco | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
XOMA CORPORATION | Health Technology |
COMPUGEN LTD. | Health Technology |
FIBROGEN, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Compugen, Inc. (United States) | |
Keyhole Therapeutics, Inc. |